Starting in 2010, Part B of Medicare will not be reimbursed to pharmacists.  The Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 592 / S. 109) was introduced in January 2017 in the House of Representatives and the Senate.   This would allow pharmacists to be compensated through Medicare Part B for the provision of health services in communities underserved by state-defined health care.  These must be services for which pharmacists are licensed in their respective state and services for which doctors would have been compensated under Medicare.  According to the PPAC, a certified pharmacist-clinician is authorized to register for a personal number from DeA (Drug Enforcement Administration). His field of activity is mainly general medicine and therapeutics. Currently, they have a normative authority for these three types of disease status: high cholesterol, diabetes and hypertension in specific disease management protocols.  Work together; Share practical trends and responsibilities Geographic proximity and coverage in the event of absence, incapacity to work, disability or emergency by the licensed practitioner. (For example, licensed Practitioner (s) backup list). As part of the Cooperation Practices Agreement, a CPC has a pre-use of controlled and uncontrolled substances.  Pharmacists can help physicians treat chronic diseases of outpatients in different ways: Arkansan CPAs apply to individual pharmacists, practitioners called “licensed drug prescribing practitioners” and patients.
The specific disease stipulates that pharmacists administer, with indicated medications that the pharmacist can use are necessary. Pharmacists are required to document their interventions for discussion with the collaborative practitioner and must keep these records for at least 2 years after the date of registration.  Advanced pharmacy services under a CPA are described as collaborative management of drug therapy (CDTM). [a] While traditional practice for pharmacists provides that the legal authority recognizes drug-related problems (DOP) and proposes solutions for PDs to prescription persons (e.g. B physicians), pharmacists who offer CDTMs solve PDs directly when they recognize them.